Cargando…

Correction: High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196196/ https://www.ncbi.nlm.nih.gov/pubmed/35697380 http://dx.doi.org/10.1136/jitc-2021-004197corr1

Ejemplares similares

High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
por: Frigola, Joan, et al.
Publicado: (2022)

Correction: Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation
por: Herman, Bastien, et al.
Publicado: (2013)

Correction: Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation
Publicado: (2015)

Correction to: TIM-3: a tumor-associated antigen beyond checkpoint inhibition?
Publicado: (2023)

Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder
por: Wang, Hongkun, et al.
Publicado: (2018)

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
por: Váraljai, Renáta, et al.
Publicado: (2023)

Correction: Th1(high) in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC
por: Jian, Huang, et al.
Publicado: (2017)

RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC
por: Wang, Qian, et al.
Publicado: (2023)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
por: Reddy, Haritha G., et al.
Publicado: (2018)

Correction: Immune checkpoint inhibitor-associated celiac disease
Publicado: (2020)

Author Correction: Mutated processes predict immune checkpoint inhibitor therapy benefit in metastatic melanoma
por: Patterson, Andrew, et al.
Publicado: (2023)

Correction: Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC
Publicado: (2014)

Correction to: benefit incidence analysis in public health facilities in India: utilization and benefits at the national and state levels
por: Bowser, Diana, et al.
Publicado: (2019)

Correction to: Afatinib in advanced NSCLC: a profile of its use
por: Deeks, Emma D., et al.
Publicado: (2018)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Publicado: (2022)

Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Publicado: (2021)

Correction: Integrated Text Mining and Chemoinformatics Analysis Associates Diet to Health Benefit at Molecular Level
por: Jensen, Kasper, et al.
Publicado: (2014)

Correction to: Chromosome-Level Genome Assembly of Callitettix versicolor (Rice Spittlebug)
Publicado: (2022)

Correction: Aberrant Gene Expression in Dogs with Portosystemic Shunts
por: van Steenbeek, Frank G., et al.
Publicado: (2013)

Publisher Correction: The chromosome-level genome of Cherax quadricarinatus
por: Chen, Honglin, et al.
Publicado: (2023)

Correction: Chronic immune checkpoint inhibitor pneumonitis
Publicado: (2020)

Correction to: Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC
por: Frampton, James E.
Publicado: (2021)

Correction to: A Chromosome-Level Genome Assembly of the Pygmy Mole Cricket Xya riparia
Publicado: (2022)

Correction: Chromosome-Level Genome Assembly and Annotation of a Sciaenid Fish, Argyrosomus japonicus
Publicado: (2022)

Correction: Testosterone Levels Are Negatively Associated with Childlessness in Males, but Positively Related to Offspring Count in Fathers
por: Pollet, Thomas V., et al.
Publicado: (2013)

Correction: Aberrant DNA Methylation: Implications in Racial Health Disparity
por: Wang, Xuefeng, et al.
Publicado: (2016)

Correction: Chromosome-level genome assemblies of Cutaneotrichosporon spp. (Trichosporonales, Basidiomycota) reveal imbalanced evolution between nucleotide sequences and chromosome synteny
por: Kobayashi, Yuuki, et al.
Publicado: (2023)

Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2021)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Publicado: (2020)

Correction: T lymphocyte-targeted immune checkpoint modulation in glioma
Publicado: (2020)

Correction: The Presence of the Y-Chromosome, Not the Absence of the Second X-Chromosome, Alters the mRNA Levels Stored in the Fully Grown XY Mouse Oocyte
por: Xu, Baozeng, et al.
Publicado: (2015)

Correction: Interphase Chromosomes Mingle with Their Peers
por: Chanut, Françoise
Publicado: (2006)

Correction to: The Dutch Y-chromosomal landscape
por: Altena, Eveline, et al.
Publicado: (2019)

Correction to: Osimertinib as first-line therapy in advanced NSCLC: a profile of its use
por: Scott, Lesley J.
Publicado: (2018)

Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
por: Lamb, Yvette N.
Publicado: (2021)

Correction to: The impact of dysfunctional tear films and optical aberrations on chronic migraine
por: Shetty, Rohit, et al.
Publicado: (2017)

Correction: Aberrant iPSC-derived human astrocytes in Alzheimer’s disease
por: Jones, V. C., et al.
Publicado: (2019)

Correction: Prolonged mitosis results in structurally aberrant and over-elongated centrioles
por: Kong, Dong, et al.
Publicado: (2020)

Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
por: Simon, Malte, et al.
Publicado: (2022)

Correction: FTSJ1 regulates tRNA 2ʹ-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression
por: He, Qihan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9itjl6ombsn9kgeok7akn29r3r